Beranda4DX • ASX
add
4DMedical Ltd
Tutup sebelumnya
$0,53
Rentang hari
$0,52 - $0,54
Rentang tahun
$0,41 - $1,10
Kapitalisasi pasar
219,63Â jt AUD
Volume Rata-Rata
1,00Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
ASX
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(AUD) | Jun 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 1,48Â jt | 1.172,70% |
Biaya operasional | 12,56Â jt | 11,42% |
Laba bersih | -10,19Â jt | -33,78% |
Margin laba bersih | -687,84 | 89,49% |
Penghasilan per saham | — | — |
EBITDA | -11,09Â jt | -5,51% |
Tarif pajak efektif | -0,01% | — |
Neraca
Total aset
Total liabilitas
(AUD) | Jun 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 30,61Â jt | -56,01% |
Total aset | 120,02Â jt | 29,16% |
Total liabilitas | 49,09Â jt | 128,71% |
Total ekuitas | 70,93 jt | — |
Saham yang beredar | 410,53 jt | — |
Harga terhadap nilai buku | 3,12 | — |
Tingkat pengembalian aset | -23,28% | — |
Tingkat pengembalian modal | -36,73% | — |
Arus Kas
Perubahan kas bersih
(AUD) | Jun 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | -10,19Â jt | -33,78% |
Kas dari operasi | -8,06Â jt | 8,54% |
Kas dari investasi | -339,48Â rb | -21,29% |
Kas dari pembiayaan | -233,98Â rb | -101,11% |
Perubahan kas bersih | -8,64Â jt | -172,48% |
Arus kas bebas | -5,43Â jt | 13,25% |
Tentang
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
Didirikan
2013
Situs
Karyawan
145